India's growing population of over 1 billion presents a great market opportunity for the US life science companies. With the liberalization of Indian economy and its willingness to adapt to the new technologies, timing to sell in the Indian market is now. India's large pool of talented scientific and technical manpower, low R&D cost and lower cost of manufacturing has made it an attractive destination for sourcing. Further stimulus has been given by the new Patent law passed by the Indian parliament in accordance with the TRIPS agreement of WTO. Businesses in the US lack the advantage of common experiences from others dealing with India. In many cases, they have to deal with similar issues again and again. USA-India Chamber of Commerce has taken an initiative to bring together senior executives from the Life Sciences industry with the support of industry, industry groups and the government officials to form the Biotech, Pharmaceuticals and Healthcare Council.
To provide a professional platform for senior management in the Life Sciences industry in the US to network, facilitate & promote business, investments, workforce activities, discuss critical issues, share best practices and experiences working with their India initiative.
Sales opportunities in India
IP and Patent issues
Track Industry Trends
In-Licensing, Out-Licensing and Partnership Opportunities
Clinical Trials Opportunities
Sharing Positive and Negative Experiences
Interact with Indian government for Biotech, Pharma and Healthcare Policy
Issue specific advocacy with Indian Government
Issue specific advocacy with the US Government
CEO/CFO/CSO/CRO/VP/Director (Only for senior Life Sciences executives) and Senior Government Officials
USA India Chamber of Commerce BPH Council participation is by invitation only
Karun Rishi, President, USA-India Chamber of Commerce
Tel: 781 586-1212